We are live on
!
Find out more
CC
Colrain Capital Portfolio holdings
AUM
$259M
1-Year Est. Return
63.6%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
–
Cap. Flow
+$106M
Cap. Flow
% of AUM
104.06%
Top 10 Holdings %
Top 10 Hldgs %
67.9%
Holding
27
New
27
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$14.1M |
| 2 |
HES
Hess
HES
|
+$12M |
| 3 |
Vicor
VICR
|
+$9.49M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$6.79M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$6.42M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.15% |
| 2 | Energy | 16.28% |
| 3 | Technology | 14.84% |
| 4 | Utilities | 13.74% |
| 5 | Materials | 13.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vistra
VST
$56.5B
| $14M | 13.74% |
+101,650
| New | +$14.1M |
|
|
HES
2
DELISTED
Hess
HES
| $11.5M | 11.24% |
+86,150
| New | +$12M |
|
|
3
Vicor
VICR
$10.2B
| $9.18M | 9% |
+190,002
| New | +$9.49M |
|
|
4
Alphabet (Google) Class A
GOOGL
$4.23T
| $6.94M | 6.81% |
+36,675
| New | +$6.42M |
|
|
5
Bristol-Myers Squibb
BMY
$124B
| $6.87M | 6.74% |
+121,500
| New | +$6.79M |
|
6
Antero Resources
AR
$10.8B
| $4.67M | 4.58% |
+133,250
| New | +$4.03M |
|
7
International Paper
IP
$20.1B
| $4.35M | 4.26% |
+80,750
| New | +$4.33M |
|
8
The Mosaic Company
MOS
$7.27B
| $4.03M | 3.95% |
+164,000
| New | +$4.29M |
|
9
CVS Health
CVS
$140B
| $3.88M | 3.8% |
+86,350
| New | +$4.84M |
|
10
Nutrien
NTR
$32.9B
| $3.86M | 3.79% |
+85,500
| New | +$4.06M |
|
11
Newmont
NEM
$102B
| $3.82M | 3.75% |
+102,750
| New | +$4.68M |
|
12
Medtronic
MDT
$105B
| $3.07M | 3.01% |
+38,060
| New | +$3.29M |
|
13
Qualcomm
QCOM
$185B
| $3M | 2.94% |
+19,500
| New | +$3.19M |
|
14
Comcast
CMCSA
$84.5B
| $2.98M | 2.93% |
+79,500
| New | +$3.3M |
|
15
Bunge Global
BG
$24B
| $2.8M | 2.74% |
+36,000
| New | +$3.16M |
|
16
L3Harris
LHX
$53.1B
| $2.77M | 2.71% |
+13,150
| New | +$3.15M |
|
17
AbbVie
ABBV
$448B
| $2.75M | 2.7% |
+15,500
| New | +$2.85M |
|
18
Berkshire Hathaway Class B
BRK.B
$1.06T
| $2.7M | 2.64% |
+5,950
| New | +$2.75M |
|
19
Cigna
CI
$76.8B
| $2.28M | 2.23% |
+8,250
| New | +$2.63M |
|
20
Agnico Eagle Mines
AEM
$73.2B
| $1.82M | 1.79% |
+23,300
| New | +$1.92M |
|
21
Apple
AAPL
$4.75T
| $1.49M | 1.46% |
+5,948
| New | +$1.4M |
|
22
Microsoft
MSFT
$2.88T
| $1.46M | 1.44% |
+3,475
| New | +$1.48M |
|
23
Vertex Pharmaceuticals
VRTX
$121B
| $683K | 0.67% |
+1,696
| New | +$786K |
|
24
JPMorgan Chase
JPM
$923B
| $360K | 0.35% |
+1,500
| New | +$349K |
|
25
Procter & Gamble
PG
$349B
| $277K | 0.27% |
+1,650
| New | +$281K |
|
Similar funds
NAM
CCAM
QP
BFA
PW
BFP
TC
FC
Colrain Capital's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Colrain Capital, which disclosed 27 positions worth $102M. Its ten largest holdings account for 68% of the portfolio.
Its largest position is Vistra: 101,650 shares worth $14M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Energy and Technology.
- Colrain Capital's largest Q4 2024 buy was Vistra: 101,650 shares worth $14M.
- Colrain Capital's ten largest holdings make up 68% of its $102M portfolio in Q4 2024.
- Colrain Capital disclosed 27 positions in Q4 2024, its first 13F filing on record.
Based on Colrain Capital's 13F filing for Q4 2024, filed 12 Feb 2025.